The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy

Abstract Background Despite great advances in proliferative diabetic retinopathy (PDR) therapy over the last decades, one third of treated patients continue to lose vision. While resident vitreous macrophages called hyalocytes have been implicated in the pathophysiology of vitreoretinal proliferativ...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefaniya K. Boneva, Julian Wolf, Malte Jung, Gabriele Prinz, Toco Y. P. Chui, Jacqueline Jauch, Anne Drougard, J. Andrew Pospisilik, Anja Schlecht, Felicitas Bucher, Richard B. Rosen, Hansjürgen Agostini, Günther Schlunck, Clemens A. K. Lange
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-024-03291-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147599081406464
author Stefaniya K. Boneva
Julian Wolf
Malte Jung
Gabriele Prinz
Toco Y. P. Chui
Jacqueline Jauch
Anne Drougard
J. Andrew Pospisilik
Anja Schlecht
Felicitas Bucher
Richard B. Rosen
Hansjürgen Agostini
Günther Schlunck
Clemens A. K. Lange
author_facet Stefaniya K. Boneva
Julian Wolf
Malte Jung
Gabriele Prinz
Toco Y. P. Chui
Jacqueline Jauch
Anne Drougard
J. Andrew Pospisilik
Anja Schlecht
Felicitas Bucher
Richard B. Rosen
Hansjürgen Agostini
Günther Schlunck
Clemens A. K. Lange
author_sort Stefaniya K. Boneva
collection DOAJ
description Abstract Background Despite great advances in proliferative diabetic retinopathy (PDR) therapy over the last decades, one third of treated patients continue to lose vision. While resident vitreous macrophages called hyalocytes have been implicated in the pathophysiology of vitreoretinal proliferative disease previously, little is known about their exact role in PDR. In this study, we address molecular and cellular alterations in the vitreous of PDR patients as a means towards assessing the potential contribution of hyalocytes to disease pathogenesis. Results A total of 55 patients were included in this study encompassing RNA-Sequencing analysis of hyalocytes isolated from the vitreous of PDR and control patients, multiplex immunoassay and ELISA analyses of vitreous samples from PDR and control patients, as well as isolation and immunohistochemical staining of cultured porcine hyalocytes. Transcriptional analysis revealed an enhanced inflammatory response of hyalocytes contributing to the cytokine pool within the vitreous of PDR patients by expressing interleukin-6, among others. Further, increased angiopoietin-2 expression indicated that hyalocytes from PDR patients undergo a proangiogenic shift and may thus mediate the formation of retinal neovascularizations, the hallmark of PDR. Finally, RNA-Sequencing revealed an upregulation of factors known from hemoglobin catabolism in hyalocytes from PDR patients. By immunohistochemistry, cultured porcine hyalocytes exposed to red blood cells were shown to engulf and phagocytose these, which reveals hyalocytes’ potential to dispose of erythrocytes. Thus, our data suggest a potential role for vitreous macrophages in erythrophagocytosis and, thereby, clearance of vitreous hemorrhage, a severe complication of PDR. Conclusion Our results strongly indicate a critical role for vitreous hyalocytes in key pathophysiological processes of proliferative diabetic retinopathy: inflammation, angiomodulation and erythrophagocytosis. Immunomodulation of hyalocytes may thus prove an essential novel therapeutic approach in diabetic vitreoretinal disease.
format Article
id doaj-art-827468ebd85945bda91aa82c724d8c7e
institution Kabale University
issn 1742-2094
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj-art-827468ebd85945bda91aa82c724d8c7e2024-12-01T12:37:52ZengBMCJournal of Neuroinflammation1742-20942024-11-0121111610.1186/s12974-024-03291-5The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathyStefaniya K. Boneva0Julian Wolf1Malte Jung2Gabriele Prinz3Toco Y. P. Chui4Jacqueline Jauch5Anne Drougard6J. Andrew Pospisilik7Anja Schlecht8Felicitas Bucher9Richard B. Rosen10Hansjürgen Agostini11Günther Schlunck12Clemens A. K. Lange13Eye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgDepartment of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount SinaiEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgDepartment of Epigenetics, Van Andel Research InstituteDepartment of Epigenetics, Van Andel Research InstituteEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgDepartment of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount SinaiEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgEye Center, Medical Center, Faculty of Medicine, University Medical Center FreiburgAbstract Background Despite great advances in proliferative diabetic retinopathy (PDR) therapy over the last decades, one third of treated patients continue to lose vision. While resident vitreous macrophages called hyalocytes have been implicated in the pathophysiology of vitreoretinal proliferative disease previously, little is known about their exact role in PDR. In this study, we address molecular and cellular alterations in the vitreous of PDR patients as a means towards assessing the potential contribution of hyalocytes to disease pathogenesis. Results A total of 55 patients were included in this study encompassing RNA-Sequencing analysis of hyalocytes isolated from the vitreous of PDR and control patients, multiplex immunoassay and ELISA analyses of vitreous samples from PDR and control patients, as well as isolation and immunohistochemical staining of cultured porcine hyalocytes. Transcriptional analysis revealed an enhanced inflammatory response of hyalocytes contributing to the cytokine pool within the vitreous of PDR patients by expressing interleukin-6, among others. Further, increased angiopoietin-2 expression indicated that hyalocytes from PDR patients undergo a proangiogenic shift and may thus mediate the formation of retinal neovascularizations, the hallmark of PDR. Finally, RNA-Sequencing revealed an upregulation of factors known from hemoglobin catabolism in hyalocytes from PDR patients. By immunohistochemistry, cultured porcine hyalocytes exposed to red blood cells were shown to engulf and phagocytose these, which reveals hyalocytes’ potential to dispose of erythrocytes. Thus, our data suggest a potential role for vitreous macrophages in erythrophagocytosis and, thereby, clearance of vitreous hemorrhage, a severe complication of PDR. Conclusion Our results strongly indicate a critical role for vitreous hyalocytes in key pathophysiological processes of proliferative diabetic retinopathy: inflammation, angiomodulation and erythrophagocytosis. Immunomodulation of hyalocytes may thus prove an essential novel therapeutic approach in diabetic vitreoretinal disease.https://doi.org/10.1186/s12974-024-03291-5HyalocytesVitreous macrophagesProliferative diabetic retinopathyInflammationAngiomodulationErythrophagocytosis
spellingShingle Stefaniya K. Boneva
Julian Wolf
Malte Jung
Gabriele Prinz
Toco Y. P. Chui
Jacqueline Jauch
Anne Drougard
J. Andrew Pospisilik
Anja Schlecht
Felicitas Bucher
Richard B. Rosen
Hansjürgen Agostini
Günther Schlunck
Clemens A. K. Lange
The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
Journal of Neuroinflammation
Hyalocytes
Vitreous macrophages
Proliferative diabetic retinopathy
Inflammation
Angiomodulation
Erythrophagocytosis
title The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
title_full The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
title_fullStr The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
title_full_unstemmed The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
title_short The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
title_sort multifaceted role of vitreous hyalocytes orchestrating inflammation angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
topic Hyalocytes
Vitreous macrophages
Proliferative diabetic retinopathy
Inflammation
Angiomodulation
Erythrophagocytosis
url https://doi.org/10.1186/s12974-024-03291-5
work_keys_str_mv AT stefaniyakboneva themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT julianwolf themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT maltejung themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT gabrieleprinz themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT tocoypchui themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT jacquelinejauch themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT annedrougard themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT jandrewpospisilik themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT anjaschlecht themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT felicitasbucher themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT richardbrosen themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT hansjurgenagostini themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT guntherschlunck themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT clemensaklange themultifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT stefaniyakboneva multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT julianwolf multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT maltejung multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT gabrieleprinz multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT tocoypchui multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT jacquelinejauch multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT annedrougard multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT jandrewpospisilik multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT anjaschlecht multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT felicitasbucher multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT richardbrosen multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT hansjurgenagostini multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT guntherschlunck multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy
AT clemensaklange multifacetedroleofvitreoushyalocytesorchestratinginflammationangiomodulationanderythrophagocytosisinproliferativediabeticretinopathy